New p40 Mouse Monoclonal Antibody Available from Biocare Medical

Biocare Medical is proud to announce the availability of a new highly specific p40 mouse monoclonal antibody (IVD). Mouse monoclonal anti-p40 [BC28] demonstrated similar sensitivity and specificity as the rabbit polyclonal p40, staining 97% (65/67) of cases of lung squamous cell carcinoma (SqCC) and 0% (0/71) cases of lung adenocarcinoma (ADC), in an in-house study. […]

Ventana and Biocare Medical sign p63 license agreement to aid in the differential diagnosis of benign and malignant prostate lesions

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group and Biocare Medical, LLC (Biocare) today announced that they have entered into a non-exclusive license agreement to allow Biocare access to certain patents and materials related to p63 diagnostics in the research and IVD field. In parallel, Biocare and AsymmetRx Medical, Inc. (AsymmetRx) have […]

Biocare Medical Launches Key Diagnostic Kit to Identify Folate Receptor Alpha Expression

-New Assay, Developed in Collaboration with Morphotek, Uses Proprietary Technology- Concord, CA and Exton, PA, March 20, 2012 – In partnership with Morphotek® Inc., a subsidiary of Eisai Inc., Biocare Medical announced the release of its in vitro diagnostic immunohistochemical (IHC) kit to detect folate receptor alpha (FRalpha) expression in formalin fixed paraffin embedded (FFPE) […]

Biocare Medical expands its PromARK™ detection product line to horse, cow, pig & sheep tissues

Biocare Medical proudly introduces four newly developed horseradish peroxidase (HRP) and alkaline phosphatase (AP) polymer detection systems for horse, cow, pig and sheep tissues. These Mouse-on-Farma and Rabbit-on-Farma HRP and AP polymers are specifically designed to achieve excellent staining quality when using mouse or rabbit primary antibodies. The advanced polymer technology virtually eliminates cross-reactivity to […]

Biocare Medical Is Once Again Named One of America’s Fastest-Growing Private Companies on Inc. Magazine’s Exclusive List, Inc. 500|5000

Biocare Medical Ranks No. 2781 on the 2011 Inc. 500 | 5000 with Three-Year Sales Growth of 79% Concord, CA, October 10, 2011 – Biocare Medical ranked No. 2781 in Inc. Magazine’s fifth annual Inc. 500|5000, an exclusive ranking of the nation’s fastest-growing private companies. This represents the third consecutive year that Biocare Medical has […]

Biocare Medical Launches a New Monoclonal PAX8 Antibody; Exhibiting Higher Specificity and Sharper Staining

Biocare Medical is proud to announce the launch of a mouse monoclonal PAX8 antibody. Unlike current existing PAX8 polyclonals, the PAX8 mouse clone [BC12] has been designed for specific epitope targeting. The monoclonal PAX8 does not stain B-cells, cells of pancreatic origin or neuroendocrine cells of the stomach or colon. This antibody also has lower […]

Biocare Medical launches a highly specific six antibody panel for differentiation of adenocarcinoma vs. squamous cell carcinoma of the lung

Biocare Medical is proud to announce the launch of the PulmoPanel™ Multiplex IHC to clearly differentiate between adenocarcinoma (LADC) and squamous cell carcinoma (SqCC) of the lung with 97% specificity and 93% sensitivity. This Multiplex IHC contains six antibodies (TTF-1, Napsin A, p63, TRIM29, Desmoglein 3 and CK5), and aids in the critical differentiation of […]

Biocare Medical Announces Agreement with Morphotek®, Inc. To Develop and Commercialize A Diagnostic Kit for Detection of Folate Receptor Alpha in Malignant Tissues

Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it has entered into a collaboration and license agreement with Biocare Medical, LLC. Under the agreement, the parties will collaborate to develop and commercialize an immunohistochemical (IHC) diagnostic kit utilizing Morphotek’s proprietary monoclonal antibody to specifically detect human folate receptor alpha (FRA) with Biocare’s intelliPATH™ […]

Biocare Medical launches a highly specific ERG monoclonal antibody to detect prevalent oncogenic alterations in prostate cancer

Biocare Medical is proud to announce the launch of the anti-ERG monoclonal antibody (clone 9FY CPDR) for in-vitro diagnostics, prognostics, patient monitoring, and screening by immunohistochemistry. The ERG oncoprotein is a promising diagnostic marker for identifying prostatic adenocarcinoma and distinguishing it from non-neoplastic prostate and other adenocarcinomas. This ERG antibody is 99.6% specific for prostate […]

Biocare Medical expands its Promark™ product line to canine applications.

Biocare Medical proudly introduces two newly developed HRP-Polymer detection systems, the Mouse-on-Canine HRP-Polymer and Rabbit-on-Canine HRP-Polymer. These polymers are specifically designed to achieve excellent staining quality when using mouse or rabbit primary antibodies on canine tissues. This addition to Biocare’s Promark series expands IHC detection applications to a broader range of animal tissues, resulting in […]

Email Cart